Clinical Trials on Neurofibromatoses in United Kingdom
Total 170 results
-
Guy's and St Thomas' NHS Foundation TrustRecruitingNeurofibromatosis Type 1United Kingdom
-
Guy's and St Thomas' NHS Foundation TrustCompletedNeurofibromatosis 1, NF1United Kingdom
-
Manchester University NHS Foundation TrustManchester Metropolitan UniversityCompletedMuscle Weakness | Neurofibromatosis Type 1United Kingdom
-
University of ManchesterCompletedNeurofibromatosis 1United Kingdom
-
University of ManchesterCompletedNeurofibromatosis 1United Kingdom
-
Guy's and St Thomas' NHS Foundation TrustCompletedNeurofibromatosis 2United Kingdom
-
Manchester University NHS Foundation TrustCompletedNeurofibromatosis Type 2United Kingdom
-
Great Ormond Street Hospital for Children NHS Foundation...AstraZenecaCompletedNeurofibromatosis Type 1 | Optic Nerve Glioma | Plexiform NeurofibromaUnited Kingdom
-
AstraZenecaRecruitingNeurofibromatosis Type 1Portugal, Spain, United Kingdom, Israel, France, Italy, Switzerland, Germany, Austria
-
University of UtahUniversity of British Columbia; Children's Hospital Medical Center, Cincinnati and other collaboratorsTerminatedNeurofibromatosis Type 1 (NF1)United States, Canada
-
Johns Hopkins UniversityNeurofibromatosis Therapeutic Acceleration ProgramRecruitingNeurofibromatosis 1 | Neurofibromatosis Type 1 | Cutaneous Neurofibroma | Neurofibromatosis (Nonmalignant)United States
-
National Cancer Institute (NCI)CompletedPlexiform Neurofibroma | Neurofibromatosis Type IUnited States
-
National Cancer Institute (NCI)CompletedNeurofibromatosis Type 1 | Legius SyndromeUnited States
-
Cardiff UniversityUniversity of CanterburyRecruitingCleft Lip and Palate | Parenting | Neurofibromatoses | Skin Condition | Alopecia | Craniofacial | Limb DifferenceUnited Kingdom
-
Ann & Robert H Lurie Children's Hospital of ChicagoNational Institute of Neurological Disorders and Stroke (NINDS); Children's...RecruitingNeurofibromatosis 1 | Neurofibromatosis Type 1 | NF1United States
-
Donald BaselRecruiting
-
National Cancer Institute (NCI)CompletedNeurofibroma | Neurofibromatosis Type 1United States
-
Shriners Hospitals for ChildrenUniversity of Utah; Thrasher Research FundCompletedNeurofibromatosis Type 1United States
-
Children's National Research InstituteEmory University; University of Texas Southwestern Medical Center; Arizona State...Completed
-
Ann & Robert H Lurie Children's Hospital of ChicagoCompleted
-
Washington University School of MedicineCompleted
-
Massachusetts General HospitalCompletedNeurofibromatosis Type 1 | Cutaneous NeurofibromasUnited States
-
Shriners Hospitals for ChildrenCompletedNeurofibromatosis Type 1United States
-
Massachusetts General HospitalJohns Hopkins UniversityActive, not recruitingCutaneous NeurofibromaUnited States
-
Case Comprehensive Cancer CenterTerminatedGlioma | Brain Tumor | Neurofibromatosis Type 1United States
-
Massachusetts General HospitalCompletedNeurofibromatosis Type 1 | Cutaneous NeurofibromasUnited States
-
Kristina HardyChildren's Hospital Los Angeles; Sydney Children's Hospitals Network; Royal Children... and other collaboratorsCompletedNeurofibromatosis Type 1United States
-
John Jay High SchoolUnknownNeurofibromatosis Type 1United States
-
AlexionRecruiting
-
University of Alabama at BirminghamCompletedNeurofibromatosis Type 1 and Growing or Symptomatic, Inoperable PNUnited States
-
AstraZenecaCompletedHealthy Participants | Neurofibromatosis Type 1 (NF1)-Related Plexiform Neurofibromas (PNs)United States
-
University of UtahNational Institute of Neurological Disorders and Stroke (NINDS)CompletedNeurofibromatosis Type 1United States
-
University of Alabama at BirminghamNational Cancer Institute (NCI); Children's Hospital of Philadelphia; Washington... and other collaboratorsCompletedNeurofibromatosis Type 1United States, Australia
-
Nicole BacaRecruiting
-
National Cancer Institute (NCI)CompletedNeurofibromatosis Type 1 | Plexiform NeurofibromasUnited States
-
Shriners Hospitals for ChildrenUniversity of UtahCompletedNeurofibromatosis Type 1 | Tibial DysplasiaUnited States
-
NYU Langone HealthNovartis Pharmaceuticals; The Children's Tumor FoundationCompletedNeurofibromatosis Type IIUnited States
-
National Cancer Institute (NCI)Active, not recruitingNeurofibromatosis 1 (NF1) | Plexiform Neurofibromas (PN)United States
-
NYU Langone HealthCompletedNeurofibromatosis 1 and 2 (NF1 and NF2)United States
-
AstraZenecaMerck Sharp & Dohme LLCActive, not recruitingNeurofibromatosis Type 1United States, Spain, Germany, Netherlands, Russian Federation, Italy, Japan
-
Children's Hospital of PhiladelphiaCompletedNeurofibromatosis Type 1 | Precancerous ConditionUnited States
-
Children's Hospital of PhiladelphiaTerminatedNeurofibromatosis Type 1 | Precancerous ConditionUnited States
-
National Cancer Institute (NCI)Active, not recruitingNeurofibromatosis 1 | Neurofibroma, Plexiform | Neurofibromatosis Type 1 | NF1United States
-
NYU Langone HealthBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaTerminatedneurofibromatosis1 (NF1) | Recurrent or Progressive Optic Pathway Gliomas (OPG) | Recurrent or Progressive Low-grade GliomaUnited States
-
National Cancer Institute (NCI)CompletedNeurofibroma, Plexiform | Neurofibromatosis Type IUnited States, Germany
-
AstraZenecaMerck Sharp & Dohme LLCActive, not recruitingNeurofibromatosis Type 1United States, Spain, Poland, Russian Federation
-
Washington University School of MedicineSt. Louis Children's HospitalTerminated
-
SpringWorks Therapeutics, Inc.Active, not recruitingPlexiform Neurofibroma | Neurofibromatosis Type 1 (NF1)United States
-
National Human Genome Research Institute (NHGRI)CompletedNeurofibromatosis Type 1 | NF1 | Von Recklinghausen DiseaseUnited States
-
Roger PackerWithdrawnNeurofibromatosis Type 1 | Tumors of the Central Nervous SystemUnited States